Spots Global Cancer Trial Database for vitamin c
Every month we try and update this database with for vitamin c cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer | NCT05501548 | Prostate Cancer Castration-resi... | Olaparib Vitamin C | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations | NCT03799094 | Carcinoma, Non-... | Vitamin C Tyrosine kinase... | 18 Years - 75 Years | Clifford Hospital, Guangzhou, China | |
| Effect of Vitamin C and E in Breast Cancer Patients Undergoing Chemotherapy | NCT04463459 | Breast Cancer | Vitamin C, Vita... | 30 Years - 70 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
| Pharmacological Ascorbate for Lung Cancer | NCT02420314 | Carcinoma, Non-... | Paclitaxel Carboplatin Ascorbic Acid | 18 Years - | University of Iowa | |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | NCT03175341 | Breast Cancer | Ascorbic Acid Placebos | 18 Years - | Academic Emergency County Hospital Sibiu | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | NCT01426490 | Colorectal Canc... | Vitamin C Vitamin B6 Folic acid Vitamin B6 plus... | 18 Years - 85 Years | Taichung Veterans General Hospital | |
| Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | NCT00661544 | Multiple Myelom... Stem Cell Trans... | Arsenic Trioxid... Melphalan Ascorbic Acid | - 70 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer | NCT02655913 | Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... Recurrent Non-s... | vitamin C Modulated Elect... Supportive care | 18 Years - 70 Years | Clifford Hospital, Guangzhou, China | |
| A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme | NCT01752491 | Glioblastoma GBM Glioblastoma Mu... | Ascorbate Temozolomide Radiation thera... | 18 Years - | University of Iowa | |
| The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | NCT01426490 | Colorectal Canc... | Vitamin C Vitamin B6 Folic acid Vitamin B6 plus... | 18 Years - 85 Years | Taichung Veterans General Hospital | |
| A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations | NCT03433781 | Myelodysplastic... | Vitamin C | 18 Years - | NYU Langone Health | |
| The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients | NCT03224572 | Vitamin C Defic... | high-dose vitam... normal saline | 20 Years - | National Taiwan University Hospital | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| Physicians' Health Study II | NCT00270647 | Cancer Prostate Cancer Colorectal Canc... Cardiovascular ... Eye Disease Cognitive Decli... | Vitamin E Vitamin C Multivitamin Beta-carotene | 50 Years - | Brigham and Women's Hospital | |
| Combining Active and Passive DNA Hypomethylation | NCT03999723 | Myelodysplastic... Acute Myeloid L... Chronic Myelomo... | Vitamin C Placebo | 18 Years - | Rigshospitalet, Denmark | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03908333 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | Medical College of Wisconsin | |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | NCT03175341 | Breast Cancer | Ascorbic Acid Placebos | 18 Years - | Academic Emergency County Hospital Sibiu | |
| Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations | NCT03799094 | Carcinoma, Non-... | Vitamin C Tyrosine kinase... | 18 Years - 75 Years | Clifford Hospital, Guangzhou, China | |
| A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma | NCT01891747 | Malignant Gliom... | Bevacizumab Temozolomide Vitamin C | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03908333 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | Medical College of Wisconsin | |
| High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | NCT04033107 | Hepatocellular ... Pancreatic Canc... Gastric Cancer Colorectal Canc... | Vitamin C Metformin | 18 Years - 70 Years | Zhongnan Hospital | |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer | NCT02655913 | Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... Recurrent Non-s... | vitamin C Modulated Elect... Supportive care | 18 Years - 70 Years | Clifford Hospital, Guangzhou, China | |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449 | Sarcoma Adenocarcinoma Carcinoma Multiple Myelom... Desmoplastic Sm... | Ascorbic acid (... | 18 Years - | Situs Cancer Research Center | |
| Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
| Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03797443 | Metastatic Panc... | Ascorbic Acid nab paclitaxel Cisplatin Gemcitabine | 18 Years - | Piedmont Cancer Institute | |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449 | Sarcoma Adenocarcinoma Carcinoma Multiple Myelom... Desmoplastic Sm... | Ascorbic acid (... | 18 Years - | Situs Cancer Research Center | |
| Potentiation of Chemotherapy in Brain Tumors by Zinc | NCT04488783 | Newly Diagnosed... | zinc and ascorb... | 18 Years - 90 Years | Sheba Medical Center | |
| Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | NCT00661544 | Multiple Myelom... Stem Cell Trans... | Arsenic Trioxid... Melphalan Ascorbic Acid | - 70 Years | M.D. Anderson Cancer Center | |
| Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | NCT01905150 | Pancreatic Canc... | G-FLIP G-FLIP-DM Vitamin C | 18 Years - | Bruckner Oncology | |
| Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients | NCT00469209 | Myeloma | Trisenox (Arsen... Velcade (Bortez... Melphalan Vitamin C (Asco... | - 75 Years | M.D. Anderson Cancer Center | |
| Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | NCT01905150 | Pancreatic Canc... | G-FLIP G-FLIP-DM Vitamin C | 18 Years - | Bruckner Oncology | |
| Effect of Vitamin C in Autologous Stem Cell Transplantations | NCT03964688 | Myeloma Multipl... Lymphoma | Vitamin C Placebos | 18 Years - | Maastricht University Medical Center | |
| Pharmacological Ascorbate for Lung Cancer | NCT02420314 | Carcinoma, Non-... | Paclitaxel Carboplatin Ascorbic Acid | 18 Years - | University of Iowa | |
| The Effect of Green Tea and Vitamin C on Skin Health | NCT01032031 | Skin Cancer | Green tea + vit... Placebo capsule | 18 Years - 65 Years | University of Manchester | |
| Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | NCT01852890 | Pancreatic Neop... | Ascorbate Gemcitabine Radiation thera... | 18 Years - | University of Iowa | |
| Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer | NCT06336902 | Metastatic Colo... Stage IV Colore... | Balstilimab Biospecimen Col... Botensilimab Computed Tomogr... Dietary Interve... Magnetic Resona... Vitamin C | 18 Years - | University of Southern California | |
| Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective | NCT01050621 | Cancer | vitamin C (asco... | 18 Years - | Jewish General Hospital | |
| Ascorbic Acid Levels in MDS, AML, and CMML Patients | NCT03526666 | Myelodysplastic... Acute Myeloid L... Chronic Myelomo... MDS AML CMML | Peripheral bloo... | 18 Years - | Van Andel Research Institute | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03797443 | Metastatic Panc... | Ascorbic Acid nab paclitaxel Cisplatin Gemcitabine | 18 Years - | Piedmont Cancer Institute | |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | NCT02905578 | Pancreatic Neop... Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... Adenocarcinoma | Gemcitabine nab-paclitaxel Pharmacological... | 18 Years - | University of Iowa | |
| Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | NCT01852890 | Pancreatic Neop... | Ascorbate Gemcitabine Radiation thera... | 18 Years - | University of Iowa | |
| Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
| A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations | NCT03433781 | Myelodysplastic... | Vitamin C | 18 Years - | NYU Langone Health | |
| Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients | NCT03613727 | Lymphoid Leukem... Myeloid Leukemi... Monocytic Leuke... Myelodysplasia | Intravenous (IV... | 18 Years - 77 Years | Virginia Commonwealth University | |
| Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer | NCT04801511 | Rectal Cancer | Vitamin C | 18 Years - 70 Years | Zhongnan Hospital | |
| The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients | NCT03224572 | Vitamin C Defic... | high-dose vitam... normal saline | 20 Years - | National Taiwan University Hospital | |
| Safety of Antioxidants During GYN Cancer Care | NCT00284427 | Ovarian Cancer Cervical Cancer Uterine Cancer | vitamin C | - | University of Kansas Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
